PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
21-Sep-2020 Latest report: Global Venous Stents Market|Boston Scientific, Medtronic, Veniti, Cook Medical, Optimed Med, and C.R. Bard Lexis Business Insights
18-Sep-2020 Chi-Med Announces Second NDA Acceptance in China for Surufatinib in Pancreatic Neuroendocrine Tumors Surufatinib
18-Sep-2020 Vifor Pharma Group announces successful sale of OM Pharma Vifor Pharma Group
18-Sep-2020 UCB launches Community Health Fund to support vulnerable young people post-COVID-19 crisis UCB
18-Sep-2020 Lynparza improved median time patients lived without disease progression to over four and half years in BRCA-mutated advanced ovarian cancer vs. just over one year with placebo AstraZeneca
17-Sep-2020 PharmiWeb.Jobs Welcomes Northreach Northreach
17-Sep-2020 2020 PM Society Digital Awards - Winners Announced PM Society
17-Sep-2020 Huntington Study Group Announces a Partnership with Prilenia Therapeutics to Conduct a Global Phase 3 Clinical Study of Pridopidine in Huntington’s Disease Huntington Study Group
16-Sep-2020 Global Ornithine Transcarbamylase Market Professional Survey Research Report 2020-2028 LBI
16-Sep-2020 Global Rabies Monoclonal Antibody Market Professional Survey Research Report 2020-2028 LBI
16-Sep-2020 COVID-19 vaccine AZD1222 clinical trials resumed in the UK AstraZeneca
15-Sep-2020 Time for the adaptive profession – APM reveals findings of its Projecting the Future report Association for Project Management (APM)
15-Sep-2020 Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalised Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial Eli Lilly and Company
09-Sep-2020 PCR Biosystems launches RiboShield™ RNase Inhibitor to ensure reliable RNA protection PCR Biosystems
08-Sep-2020 HRA PHARMA RARE DISEASES: FIRST PROSPECTIVE STUDY CONFIRMS THAT METYRAPONE EFFECTIVELY LOWERS UFC LEVELS IN PATIENTS WITH ENDOGENOUS CUSHING’S SYNDROME HRA Pharma
08-Sep-2020 CORONA Remedies picks up stake in La Chandra Pharmalab La Chandra Pharmalab
07-Sep-2020 Farxiga demonstrated unprecedented reduction in the risk of kidney failure and cardiovascular or renal death in patients with chronic kidney disease in the Phase III DAPA-CKD trial AstraZeneca
07-Sep-2020 SCOTTISH MEDICINES CONSORTIUM (SMC) ACCEPTS SPRAVATO®▼ (ESKETAMINE) NASAL SPRAY FOR USE IN TREATMENT OF ADULTS WITH TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER IN SCOTLAND Janssen
01-Sep-2020 Chromologics Announces Seed Round Led by Novo Holdings and Supported by Vækstfonden and Nordic FoodTech VC Chromologics
01-Sep-2020 Imfinzi approved in the EU for the treatment of extensive-stage small cell lung cancer AstraZeneca